July 10, 2020
electroCore to Participate in Three Upcoming Virtual Investor Conferences
BASKING RIDGE, N.J., July 09, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that Dan Goldberger, Chief Executive Officer, ...
July 10, 2020
Inspire Medical Systems, Inc. Announces Appointment of Veteran Consumer Marketing Executive Georgia Garinois-Melenikiotou to its Board of Directors
MINNEAPOLIS, July 09, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of ...
July 10, 2020
Bionano Genomics Solidifies its Entry into Solid Tumor Analysis with Launch of New Kit and Protocol that Significantly Simplify Tissue and Solid Tumor Analysis
SAN DIEGO, July 09, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that it has launched the new Bionano PrepTM SP Tissue ...
July 10, 2020
Basilea announces the start of the offer period of its partial repurchase offer for its outstanding convertible bonds due 2022
After publication of the Offer Notice on 25 June 2020 and the end of the cooling-off period, Basilea Pharmaceutica Ltd. (SIX: BSLN, the “Offeror”) announces ...
July 10, 2020
Nicox Strengthens Cash Position With Divestment of its VISUfarma Shareholding
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that it has sold its remaining stake in VISUfarma, a pan-European ophthalmic specialty ...
July 10, 2020
Nicox Partner Ocumension Completes Successful Hong Kong IPO at an approximately US$1,090 Million Valuation
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today congratulated its partner Ocumension Therapeutics on its successful IPO on the Hong Kong Stock ...
July 10, 2020
Abeona Therapeutics Announces Two Presentations Related to Its RDEB Clinical Program at the Society for Pediatric Dermatology 45th Annual Meeting
NEW YORK and CLEVELAND, July 10, 2020 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced ...
July 10, 2020
AGENT Study Update With Regards to COVID-19
GOTHENBURG, Sweden, July 10, 2020 /PRNewswire/ -- Isofol Medical AB (publ) (Nasdaq First North Premier Growth Market: ISOFOL), informs that the outbreak of COVID-19 has ...
July 7, 2020
Inspire Medical Systems, Inc. to Report Second Quarter 2020 Financial Results on August 4, 2020
MINNEAPOLIS, July 07, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative ...
July 7, 2020
CohBar Resumes CB4211 Phase 1b Clinical Trial
MENLO PARK, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases ...
July 7, 2020
Tau-PET Tracer PI-2620 Could Set New Standards for an Improved Diagnosis of Progressive Supranuclear Palsy
BERLIN and LAUSANNE, Switzerland, July 07, 2020 (GLOBE NEWSWIRE) -- Life Molecular Imaging and AC Immune SA (ACIU) announce the publication of clinical data of ...
June 30, 2020
MediWound Announces Submission of Biologics License Application to the U.S. FDA for NexoBrid for the Treatment of Severe Thermal Burns
YAVNE, Israel, June 30, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet medical needs in severe ...
June 30, 2020
Marinus Pharmaceuticals Provides Pipeline Update
RADNOR, Pa., June 30, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare ...
June 30, 2020
Altimmune Announces Dosing of First Patient in Phase 1b Clinical Trial of NasoShield™, a Single Dose Intranasal Anthrax Vaccine Candidate
GAITHERSBURG, Md., June 30, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, today announced dosing of the first patient in the Company’s ...
June 30, 2020
BioInvent Submits a CTA for a Phase I/IIa trial of BI-1808, A First-in-class Anti-TNFR2 Antibody for the Treatment of Patients With Solid Tumors and CTCL
LUND, Sweden, June 30, 2020 /PRNewswire/ -- BioInvent International AB ("BioInvent") (OMXS: BINV), a biotech company focused on the discovery and development of novel and ...
June 30, 2020
CohBar Added to Russell 2000® Index and Raises $4.4M in ATM Offering
MENLO PARK, Calif., June 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases ...
June 24, 2020
HTG EdgeSeq Technology Highlighted in Multiple Posters Presented by Pharma Partners at the 2020 American Association for Cancer Research Virtual Meeting
TUCSON, Ariz., June 23, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a life science company whose mission is to advance precision medicine, ...
June 24, 2020
Medigene enters Phase I clinical development with its TCR-T immunotherapy MDG1021 in hematological cancers
MARTINSRIED, Germany and MUNICH, Germany, June 23, 2020 (GLOBE NEWSWIRE) -- Medigene AG (FSE: MDG1, Prime Standard), a clinical stage immuno-oncology company focusing on the ...
June 24, 2020
Amryt publicly files registration statement for impending US listing on Nasdaq
DUBLIN, Ireland, and Boston MA, June 23, 2020, Amryt Pharma (AIM: AMYT, Euronext Growth: AYP), a global, commercial-stage biopharmaceutical company dedicated to developing and commercializing ...
June 24, 2020
Basilea launches the placement of CHF 100 million senior convertible bonds with an increase option of CHF 25 million
Basilea Pharmaceutica Ltd. (SIX: BSLN, the “Issuer”) announces the launch of CHF 100 million senior unsecured convertible bonds due 2027 (the “Bonds”), with a provisional ...
Page 106 of 205